These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 32395143)
1. Interstitial high-dose-rate brachytherapy as a boost in synchronous prostate and rectal cancer treatment: case report and literature review. Konat-Bąska K; Chicheł A; Staszek-Szewczyk U; Maciejczyk A; Matkowski R J Contemp Brachytherapy; 2020 Apr; 12(2):181-187. PubMed ID: 32395143 [TBL] [Abstract][Full Text] [Related]
2. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929 [TBL] [Abstract][Full Text] [Related]
3. Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. Gorovets D; Hopkins M; Kollmeier M; Moore A; Goel A; Shasha D; Brennan V; McBride S; Cohen G; Damato AL; Zelefsky MJ Brachytherapy; 2021; 20(6):1099-1106. PubMed ID: 34588146 [TBL] [Abstract][Full Text] [Related]
4. The curative management of synchronous rectal and prostate cancer. Lavan NA; Kavanagh DO; Martin J; Small C; Joyce MR; Faul CM; Kelly PJ; O'Riordain M; Gillham CM; Armstrong JG; Salib O; McNamara DA; McVey G; O'Neill BD Br J Radiol; 2016; 89(1057):20150292. PubMed ID: 26539631 [TBL] [Abstract][Full Text] [Related]
5. Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: is lymph node sampling necessary? Kovács G; Galalae R Cancer Radiother; 2003 Apr; 7(2):100-6. PubMed ID: 12719039 [TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
7. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358 [TBL] [Abstract][Full Text] [Related]
8. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Pellizzon AC; Nadalin W; Salvajoli JV; Fogaroli RC; Novaes PE; Maia MA; Ferrigno R Radiother Oncol; 2003 Feb; 66(2):167-72. PubMed ID: 12648788 [TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort. Marotte D; Gal J; Schiappa R; Gautier M; Boulahssass R; Chand-Fouche ME; Hannoun-Levi JM Clin Transl Radiat Oncol; 2022 Jul; 35():104-109. PubMed ID: 35692263 [TBL] [Abstract][Full Text] [Related]
10. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653 [TBL] [Abstract][Full Text] [Related]
11. Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer. Parzen JS; Ye H; Gustafson G; Yan D; Martinez A; Chen PY; Ghilezan M; Sebastian E; Limbacher A; Krauss DJ Radiother Oncol; 2020 Jun; 147():123-129. PubMed ID: 32276193 [TBL] [Abstract][Full Text] [Related]
12. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018 [TBL] [Abstract][Full Text] [Related]
13. External beam radiotherapy plus single-fraction high dose rate brachytherapy in the treatment of locally advanced prostate cancer. Boladeras A; Santorsa L; Gutierrez C; Martinez E; Pera J; Pino F; Suarez JF; Ferrer F; Díaz A; Polo A; Guedea F Radiother Oncol; 2014 Aug; 112(2):227-32. PubMed ID: 25174299 [TBL] [Abstract][Full Text] [Related]
14. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer. Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052 [TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate. Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833 [TBL] [Abstract][Full Text] [Related]
16. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
17. A dose escalated fiducial marker-based image guided radical radiotherapy in locally advanced prostate cancers: A single institute experience from India. Gupta PK; Rastogi N; Maria Das KJ; Kumar S J Cancer Res Ther; 2023; 19(2):382-388. PubMed ID: 37006073 [TBL] [Abstract][Full Text] [Related]
18. Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial. Palvai S; Harrison M; Shibu Thomas S; Hayden K; Green J; Anderson O; Romero L; Lodge R; Burns P; Ahmed I JMIR Res Protoc; 2015 Apr; 4(2):e49. PubMed ID: 25926023 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience. Ng IWS; Tey JCS; Soon YY; Tseng MSF; Chen D; Lim KHC Asia Pac J Clin Oncol; 2018 Oct; 14(5):e386-e391. PubMed ID: 29171166 [TBL] [Abstract][Full Text] [Related]
20. Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial. Hannoun-Levi JM; Chand-Fouche ME; Pace-Loscos T; Gautier M; Gal J; Schiappa R; Pujol N Clin Transl Radiat Oncol; 2022 Nov; 37():64-70. PubMed ID: 36093342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]